Guideline for pharmacological treatment of schizophrenia 2022.
出版信息
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12497. doi: 10.1002/npr2.12497. Epub 2024 Nov 25.
Abstract
摘要
相似文献
1
Guideline for pharmacological treatment of schizophrenia 2022.
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12497. doi: 10.1002/npr2.12497. Epub 2024 Nov 25.
2
Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia.
Int J Neuropsychopharmacol. 2023 Aug 29;26(8):557-565. doi: 10.1093/ijnp/pyad037.
3
Effectiveness of a treatment guideline for schizophrenia in adolescents: Lessons from a middle-income country.
Aust N Z J Psychiatry. 2018 Feb;52(2):192-199. doi: 10.1177/0004867417726581. Epub 2017 Aug 23.
4
Developing the EPA guidance of pharmacological treatment of schizophrenia - results of a Delphi process.
Eur Psychiatry. 2025 Jan 30;68(1):e26. doi: 10.1192/j.eurpsy.2024.1794.
5
Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode.
BMJ Open. 2017 Jan 6;7(1):e013881. doi: 10.1136/bmjopen-2016-013881.
6
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology.
J Psychopharmacol. 2020 Jan;34(1):3-78. doi: 10.1177/0269881119889296. Epub 2019 Dec 12.
7
[Clinical guidelines for the management of schizophrenia: Pharmacological and psychological interventions (III)].
Psychiatriki. 2018 Oct-Dec;29(4):303-315. doi: 10.22365/jpsych.2018.294.303.
8
Treating schizophrenia: the quality of evidence behind treatment recommendations and how it can improve.
BMJ Evid Based Med. 2020 Aug;25(4):138-142. doi: 10.1136/bmjebm-2019-111233. Epub 2019 Oct 31.
9
One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.
J Clin Psychopharmacol. 2020 Nov/Dec;40(6):534-540. doi: 10.1097/JCP.0000000000001303.
10
Relationships between clinician adherence to guideline-recommended treatment and memory function in patients with schizophrenia.
J Psychiatr Res. 2025 May;185:169-176. doi: 10.1016/j.jpsychires.2025.03.054. Epub 2025 Mar 27.
引用本文的文献
1
Awareness and management of cognitive impairment associated with schizophrenia in psychiatrists and patients: Results from a cross-sectional survey.
Schizophr Res Cogn. 2025 Jun 27;42:100375. doi: 10.1016/j.scog.2025.100375. eCollection 2025 Dec.
本文引用的文献
1
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".
Neuropsychopharmacol Rep. 2021 Sep;41(3):266-324. doi: 10.1002/npr2.12193. Epub 2021 Aug 12.
2
Psychosocial interventions in schizophrenia: Focus on guidelines.
Int J Soc Psychiatry. 2020 Dec;66(8):735-747. doi: 10.1177/0020764020934827. Epub 2020 Jun 27.
3
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment.
Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534. doi: 10.2147/NDT.S225643. eCollection 2020.
4
Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis.
Lancet Psychiatry. 2020 Jan;7(1):64-77. doi: 10.1016/S2215-0366(19)30416-X. Epub 2019 Dec 17.
5
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
Neuropsychopharmacology. 2020 Apr;45(5):887-901. doi: 10.1038/s41386-019-0573-7. Epub 2019 Nov 26.
6
Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
BMC Psychiatry. 2019 Nov 14;19(1):362. doi: 10.1186/s12888-019-2318-x.
7
Determinants of clinical, functional and personal recovery for people with schizophrenia and other severe mental illnesses: A cross-sectional analysis.
PLoS One. 2019 Sep 18;14(9):e0222378. doi: 10.1371/journal.pone.0222378. eCollection 2019.
8
Relationship between polydipsia and antipsychotics: A systematic review of clinical studies and case reports.
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109756. doi: 10.1016/j.pnpbp.2019.109756. Epub 2019 Aug 28.
9
British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.
Arrhythm Electrophysiol Rev. 2019 Jul;8(3):161-165. doi: 10.15420/aer.2019.8.3.G1.
10
Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review.
Schizophr Res. 2019 Sep;211:1-9. doi: 10.1016/j.schres.2019.07.040. Epub 2019 Aug 1.
Zotero 插件